Abstract
Nociceptin (NC), also known as Orphanin FQ, is a brain peptide involved in the regulation of pain, but its role in the endocrine pancreas is poorly understood. The present study examines the pattern of distribution of NC and its effect on insulin and glucagon secretion after the onset of diabetes mellitus (DM). Male Wistar rats weighing 150–200 g were made diabetic with streptozotocin (60 mg/kg body weight, intraperitoneally). Four weeks after the induction of DM, pancreatic tissues were retrieved and processed for immunofluorescence, immunoelectron microscopy, and insulin and glucagon secretion. Isolated islets from non-diabetic and diabetic rats were used to determine the effect of NC on insulin release. NC was discerned in islet cells of non-diabetic control and diabetic rat pancreata. NC co-localized only with insulin in pancreatic beta cells. NC did not co-localize with either glucagon or somatostatin or pancreatic polypeptide. The number of NC-positive cells was markedly (p < 0.001) reduced after the onset of DM. Electron microscopy study showed that NC is located with insulin in the same secretory granules of the beta cells of both non-diabetic and diabetic rat pancreas. NC inhibits insulin release markedly (p < 0.05) from pancreatic tissue fragments of non-diabetic and diabetic rats. In contrast, NC at 10−12 M stimulates insulin release in isolated islets of DM rats. In conclusion, NC co-localizes with insulin only in the islet of Langerhans. The co-localization of NC with insulin suggests a role for NC in the regulation of pancreatic beta cell function.
Similar content being viewed by others
References
Abdulla FA, Smith PA (1997) Nociceptin inhibits T-type Ca2+ channel current in rat sensory neurons by a G-protein-independent mechanism. J Neurosci 17:8721–8728
Adeghate E, Ponery AS (2001) Large reduction in the number of galanin-immunoreactive cells in pancreatic islets of diabetic rats. J Neuroendocrinol 13:706–710
Adeghate E, Ponery AS (2002a) GABA in the endocrine pancreas: cellular localization and function in normal and diabetic rats. Tissue Cell 34:1–6
Adeghate E, Ponery AS (2002b) Ghrelin stimulates insulin secretion from the pancreas of normal and diabetic rats. J Neuroendocrinol 14:555–560
Adeghate E, Ponery A (2004) Diabetes mellitus influences the degree of colocalization of calcitonin gene-related peptide with insulin and somatostatin in the rat pancreas. Pancreas 29:311–319
Adeghate E, Tekes K (2016) Distribution of nociceptin-immunoreactive nerves in the dorsal root ganglion of GK rats. FASEB J 30:lb35–lb35
Adeghate E, Schattner P, Péter A, Dunn E, Donáth T (2001) Diabetes mellitus and its complications in a Hungarian population. Arch Physiol Biochem 109:281–291
Adeghate E, Schattner P, Dunn E (2006) An update on the etiology and epidemiology of diabetes mellitus. Ann N Y Acad Sci 1084:1–29
Adeghate E, Hameed RS, Ponery AS, Tariq S, Sheen RS, Shaffiullah M, Donáth T (2010) Streptozotocin causes pancreatic beta cell failure via early and sustained biochemical and cellular alterations. Exp Clin Endocrinol Diabetes 118:699–707
Al-Shamsi M, Amin A, Adeghate E (2006) Vitamin E decreases the hyperglucagonemia of diabetic rats. Ann N Y Acad Sci 1084:432–441
American Diabetes Association (2015) Classification and diagnosis of diabetes. Diabetes Care 38(Supplement 1):S8–S16
American Diabetes Association (2018) Diabetes care in the hospital: standards of medical care in diabetes—2018. Diabetes Care 41(Supplement 1): S144-S151
Broccardo M, Linari G, Guerrini R, Agostini S, Petrella C, Improta G (2005) The effects of [Arg14, Lys15] nociceptin/orphanin FQ, a highly potent agonist of the NOP receptor, on in vitro and in vivo gastrointestinal functions. Peptides 26:1590–1597
Calo G, Guerrini R, Rizzi A, Salvadori S, Regoli D (2000) Pharmacology of nociceptin and its receptor: a novel therapeutic target. Brit J Pharmacol 129:1261–1283
Carter JD, Dula SB, Corbin KL, Wu R, Craig S, Nunemaker CS (2009) A practical guide to rodent islet isolation and assessment. Biol Proced Online 11:3–31
Courteix C, Coudore-Civiale MA, Privat AM, Pelissier T, Eschalier A, Fialip J (2004) Evidence for an exclusive antinociceptive effect of nociceptin/orphanin FQ, an endogenous ligand for the ORL1 receptor, in two animal models of neuropathic pain. Pain 110:236–245
Csobay-Novák C, Sótonyi P, Krepuska M, Zima E, Szilágyi N, Tóth S, Szeberin Z, Acsády G, Merkely B, Tekes K (2012) Decreased plasma nociceptin/orphanin FQ levels after acute coronary syndromes. Acta Physiol Hung 99:99–110
Drucker DJ (1998) Glucagon-like peptides. Diabetes 47:159–169
Drucker DJ, Nauck MA (2006) The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 368(9548):1696–1705
D'Souza A, Howarth FC, Yanni J, Dobrzynski H, Boyett MR, Adeghate E, Bidasee KR, Singh J (2014) Chronic effects of mild hyperglycaemia on left ventricle transcriptional profile and structural remodelling in the spontaneously type 2 diabetic Goto-Kakizaki rat. Heart Fail Rev 19:65–74
Entrez Gene: OPRL1 opiate receptor-like 1 (https://en.wikipedia.org/wiki/Nociceptin_receptor#cite_note-entrez-) Accessed on: 29 November 2017
Eppens MC, Craig ME, Cusumano J, Hing S, Chan AK, Howard NJ, Silink M, Donaghue KC (2006) Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes. Diabetes Care 29:1300–1306
Escurat M, Djabali K, Huc C, Landon F, Bécourt C, Boitard C, Gros F, Portier MM (1991) Origin of the beta cells of the islets of Langerhans is further questioned by the expression of neuronal intermediate filament proteins, peripherin and NF-L, in the rat insulinoma RIN5F cell line. Dev Neurosci 13:424–432
Giuliani S, Maggi CA (1997) Prejunctional modulation by nociceptin of nerve-mediated inotropic responses in Guinea-pig left atrium. Eur J Pharmacol 332:231–236
Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE (2014) Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 103:137–149
Hadjimarkou MM, Singh A, Kandov Y, Israel Y, Pan YX, Rossi GC, Pasternak GW, Bodnar RJ (2004) Opioid receptor involvement in food deprivation-induced feeding: evaluation of selective antagonist and antisense oligodeoxynucleotide probe effects in mice and rats. J Pharmacol Exp Ther 311:1188–1202
Halford WP, Gebhardt BM, Carr DJ (1995) Functional role and sequence analysis of a lymphocyte orphan opioid receptor. J Neuroimmunol 59:91–101
Henderson G, McKnight AT (1997) The orphan opioid receptor and its endogenous ligand-nociceptin/orphanin FQ. Trends Pharmacol Sci 18:293–300
Himukashi S, Miyazaki Y, Takeshima H, Koyanagi S, Mukaida K, Shichino T, Uga H, Fukuda K (2005) Nociceptin system does not affect MAC of volatile anaesthetics. Acta Anaesthesiol Scand 49:771–773
Howarth FC, Adeghate E (2013) Epidemiology of diabetes mellitus—a global and regional perspective. Hamdan Med J 6:51–58
International Diabetes Federation (2016). Diabetes atlas. 7th edition, IDF, 166 Chaussee de La Hulpe, B-1170, Brussels, Belgium
Jenck F, Moreau JL, Martin JR, Kilpatrick GJ, Reinscheid RK, Monsma FJ Jr, Nothacker HP, Civelli O (1997) Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress. Proc Natl Acad Sci U S A 94:14854–14858
Kamei J, Ohsawa M, Kashiwazaki T, Nagase H (1999) Antinociceptive effects of the ORL1 receptor agonist nociceptin/orphanin FQ in diabetic mice. Eur J Pharmacol 370:109–116
Lachowicz JE, Shen Y, Monsma FJ Jr, Sibley DR (1995) Molecular cloning of a novel G protein-coupled receptor related to the opiate receptor family. J Neurochem 64:34–40
Larsson KP, Olsen UB, Hansen AJ (2000) Nociceptin is a potent inhibitor of N-type Ca(2+) channels in rat sympathetic ganglion neurons. Neurosci Lett 296:121–124
Linari G, Agostini S, Broccardo M, Petrella C, Improta G (2006) Regulation of pancreatic secretion in vitro by nociceptin/orphanin FQ and opioid receptors: a comparative study. Pharmacol Res 54:356–360
Lotfy M, Sing J, Rashed H, Tariq S, Zilahi E, Adeghate E (2014) Mechanisms of the beneficial and protective effects of exenatide in diabetic rats. J Endocrinol 220:291–304
Lozinska L, Weström B, Prykhodko O, Lindqvist A, Wierup N, Ahrén B, Szwiec K, Pierzynowski SG (2016) Decreased insulin secretion and glucose clearance in exocrine pancreas-insufficient pigs. Exp Physiol 101:100–112
McDowell EM, Trump BF (1976) Histologic fixatives suitable for diagnostic light and electron microscopy. Arch Path Lab Med 100:405–414
Osinski MA, Brown DR (2000) Orphanin FQ/nociceptin: a novel neuromodulator of gastrointestinal function? Peptides 21:999–1005
Ross J, Armstead WM (2005) NOC/oFQ activates ERK and JNK but not p38 MAPK to impair prostaglandin cerebrovasodilation after brain injury. Brain Res 054:95–102
Rother KI (2007) Diabetes treatment—bridging the divide. N Engl J Med 356:1499–1501
Sakoori K, Murphy NP (2008) Endogenous nociceptin (orphanin FQ) suppresses basal hedonic state and acute reward responses to methamphetamine and ethanol, but facilitates chronic responses. Neuropsychopharmacology 33:877–891
Schiene K, Tzschentke TM, Schröder W, Christoph T (2015) Mechanical hyperalgesia in rats with diabetic polyneuropathy is selectively inhibited by local peripheral nociceptin/orphanin FQ receptor and μ-opioid receptor agonism. Eur J Pharmacol 754:61–65
Schnedl WJ, Ferber S, Johnson JH, Newgard CB (1994) STZ transport and cytotoxicity: specific enhancement in GLUT2-expressing cells. Diabetes 43:1326–1333
Shetty R, Saeed T, Rashed H, Adeghate E, Singh J (2009) Effect of diabetes mellitus on acinar morphology, peroxidase concentration, and release in isolated rat lacrimal glands. Curr Eye Res 34:905–911
Tariq S, Rashed H, Nurulain SM, Emerald BS, Koturan S, Tekes K, Adeghate E (2015) Distribution of nociceptin in pancreatic islet cells of normal and diabetic rats. Pancreas 44:602–607
Tekes K, Hantos M, Bator G, Gyenge M, Laufer R, Folyovich A (2006) Endogenous nociceptin level in ischemic stroke: connection to serotonin system. Neuropsychopharmacol Hung 8:53–59
Tudurí E, Beiroa D, Stegbauer J, Fernø J, López M, Diéguez C, Nogueiras R (2016) Acute stimulation of brain mu opioid receptors inhibits glucose-stimulated insulin secretion via sympathetic innervation. Neuropharmacology 110 (Pt a):322-332
Wang JB, Johnson PS, Imai Y, Persico AM, Ozenberger BA, Eppler CM, Uhl GR (1994) cDNA cloning of an orphan opiate receptor gene family member and its splice variant. FEBS Lett 348:75–79
WHO (2017) Model Lists of Essential Medicines. http://www.who.int/medicines/publications/essentialmedicines/en/ (Accessed 15 December 2017)
Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047–1053
Yamamoto H, Uchigata Y, Okamoto H (1981) Streptozotocin and alloxan induce DNA strand breaks and poly (ADP-ribose) synthetase in pancreatic islets. Nature 294:284–286
Zadori ZS, Shujaa N, Koles L, Kiraly KP, Tekes K, Gyires K (2008) Nocistatin and nociceptin given centrally induce opioid-mediated gastric mucosal protection. Peptides 29:2257–2265
Zamboni L (1967) Buffered picric acid-formaldehyde: a new, rapid fixative for electron microscopy. J Cell Biol 35:148
Zhang M, Zheng M, Schleicher RL (1994) Autoradiographic localization of beta-endorphin binding in the pancreas. Mol Cell Neurosci 5:684–690
Acknowledgements
The authors would like to thank Mr. Rashed Hameed for technical assistance.
Funding
The study was supported by grants from the College of Medicine and Health Sciences (NP-15-41) and UAEU (ZCHS-7-2014).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Electronic supplementary material
ESM 1
(DOCX 243 kb)
Rights and permissions
About this article
Cite this article
Adeghate, E., Saeed, Z., D’Souza, C. et al. Effect of nociceptin on insulin release in normal and diabetic rat pancreas. Cell Tissue Res 374, 517–529 (2018). https://doi.org/10.1007/s00441-018-2903-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00441-018-2903-1